Skip to main content
TLX logo

TLX

Telix Pharmaceuticals Ltd
$11.87 +0.03 (+0.25%) At close · Jul 2
Market Cap
$4.02B
Shares
338,777,049

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 40
Total Value: $24,594,610
Total Shares: 2,569,972

Institutional Ownership Trend

7 quarters

Holder Concentration

Across 40 13F filers · Δ vs Dec 31, 2025
Top Holder
22.0%
Jun 2024 → Mar 2026 · range 0.0% – 100.0%
−1.8 pts
Top 5
71.5%
Jun 2024 → Mar 2026 · range 0.0% – 100.0%
+3.6 pts
Top 10
91.4%
Jun 2024 → Mar 2026 · range 0.0% – 100.0%
+6.8 pts
HHI
1,310
Jun 2024 → Mar 2026 · range 0 – 10,000
Broadly held−16

Quarterly Activity

vs Dec 31, 2025
New
11
Increased
17
Decreased
8
Sold Out
11
Unchanged
4
Holder count: 0
Institutional value: +192.8%
Shares held: +129.2%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 40 of 40
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 2007191 CUSIP 87961M105 13F (30d) 2 filings 1 filers Visit website Investor relations